[go: up one dir, main page]

IL140767A - Polycyclic thiazolidin-2-ylidene amines, process for their preparation and their use as pharmaceuticals - Google Patents

Polycyclic thiazolidin-2-ylidene amines, process for their preparation and their use as pharmaceuticals

Info

Publication number
IL140767A
IL140767A IL14076799A IL14076799A IL140767A IL 140767 A IL140767 A IL 140767A IL 14076799 A IL14076799 A IL 14076799A IL 14076799 A IL14076799 A IL 14076799A IL 140767 A IL140767 A IL 140767A
Authority
IL
Israel
Prior art keywords
pharmaceuticals
preparation
ylidene amines
thiazolidin
polycyclic
Prior art date
Application number
IL14076799A
Other languages
English (en)
Other versions
IL140767A0 (en
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL140767A0 publication Critical patent/IL140767A0/xx
Publication of IL140767A publication Critical patent/IL140767A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL14076799A 1998-07-17 1999-07-03 Polycyclic thiazolidin-2-ylidene amines, process for their preparation and their use as pharmaceuticals IL140767A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19831878A DE19831878C2 (de) 1998-07-17 1998-07-17 Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1999/004644 WO2000004006A1 (de) 1998-07-17 1999-07-03 Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
IL140767A0 IL140767A0 (en) 2002-02-10
IL140767A true IL140767A (en) 2005-12-18

Family

ID=7874197

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14076799A IL140767A (en) 1998-07-17 1999-07-03 Polycyclic thiazolidin-2-ylidene amines, process for their preparation and their use as pharmaceuticals

Country Status (26)

Country Link
US (1) US6159996A (xx)
EP (1) EP1098891B1 (xx)
JP (1) JP3541808B2 (xx)
KR (1) KR20010083118A (xx)
CN (1) CN1144797C (xx)
AR (1) AR019925A1 (xx)
AT (1) ATE301645T1 (xx)
AU (1) AU767151B2 (xx)
BR (1) BR9912151A (xx)
CA (1) CA2337838A1 (xx)
CL (1) CL2004000219A1 (xx)
DE (2) DE19831878C2 (xx)
DK (1) DK1098891T3 (xx)
ES (1) ES2246089T3 (xx)
HK (1) HK1038560A1 (xx)
HU (1) HUP0104942A3 (xx)
ID (1) ID26985A (xx)
IL (1) IL140767A (xx)
NO (1) NO318790B1 (xx)
NZ (1) NZ509395A (xx)
PL (1) PL345619A1 (xx)
PT (1) PT1098891E (xx)
RU (1) RU2236405C2 (xx)
TR (1) TR200100125T2 (xx)
WO (1) WO2000004006A1 (xx)
ZA (1) ZA200100279B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908533A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908538A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908537A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
IL149400A0 (en) * 1999-11-05 2002-11-10 Aventis Pharma Gmbh Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
AU4413601A (en) * 2000-02-26 2001-09-03 Aventis Pharma Gmbh 8,8a-dihydro-indeno(1,2-d)thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
DE10142722A1 (de) 2001-08-31 2003-03-27 Aventis Pharma Deutschland GmbH, 65929 Frankfurt C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
US7977532B2 (en) * 2002-09-05 2011-07-12 The Procter & Gamble Company Tampon with clean appearance post use
US8124582B2 (en) * 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
EP1767565B1 (en) * 2004-07-09 2015-04-01 Nissan Chemical Industries, Ltd. Process for purification of oligoanilines and oligoanilines
JP2009514915A (ja) * 2005-11-08 2009-04-09 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ インデン誘導体、それらの製造および薬剤としての使用
MX2010010659A (es) * 2008-03-31 2010-10-26 Genentech Inc Compuestos de benzopirano y benzoxepina, inhibidores de fosfoinoinositida 3-cinasas y metodos para utilizarlos.
PT2686302T (pt) 2011-03-16 2016-11-02 Mitsubishi Tanabe Pharma Corp Compostos de sulfonamida tendo atividade antagonista de trpm8

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HUP0104942A2 (hu) 2002-04-29
RU2236405C2 (ru) 2004-09-20
JP2002520404A (ja) 2002-07-09
AR019925A1 (es) 2002-03-27
DE19831878A1 (de) 2000-01-27
ATE301645T1 (de) 2005-08-15
WO2000004006A1 (de) 2000-01-27
NO318790B1 (no) 2005-05-09
JP3541808B2 (ja) 2004-07-14
HUP0104942A3 (en) 2003-12-29
AU5030899A (en) 2000-02-07
BR9912151A (pt) 2001-04-10
CN1309653A (zh) 2001-08-22
ZA200100279B (en) 2001-08-07
US6159996A (en) 2000-12-12
HK1038560A1 (en) 2002-03-22
NZ509395A (en) 2003-10-31
NO20010219D0 (no) 2001-01-12
IL140767A0 (en) 2002-02-10
DE19831878C2 (de) 2001-05-17
ES2246089T3 (es) 2006-02-01
AU767151B2 (en) 2003-10-30
NO20010219L (no) 2001-03-15
ID26985A (id) 2001-02-22
PL345619A1 (en) 2002-01-02
PT1098891E (pt) 2005-11-30
EP1098891A1 (de) 2001-05-16
TR200100125T2 (tr) 2001-05-21
DE59912402D1 (de) 2005-09-15
CN1144797C (zh) 2004-04-07
CL2004000219A1 (es) 2005-04-22
CA2337838A1 (en) 2000-01-27
DK1098891T3 (da) 2005-12-12
EP1098891B1 (de) 2005-08-10
KR20010083118A (ko) 2001-08-31

Similar Documents

Publication Publication Date Title
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HRP950217B1 (en) Novel erythromycin derivatives, method for preparing the same and use thereof as drugs
HUP0100431A3 (en) Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them
HUP0300616A3 (en) Adamantane derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP9700574A3 (en) N,n-dimethyl-(3-aryl-but-3-ene)-amine derivatives, pharmaceutical compositions containing them and process for the preparation thereof
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
HUP0303729A3 (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals and process for their preparation
HUP0102512A3 (en) Bridged indenopyrrolocarbazoles, process for their preparation, pharmaceutical compositions containing them and their use
IL137201A0 (en) Novel aromatic amides, preparation method and application as medicines
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
IL140767A (en) Polycyclic thiazolidin-2-ylidene amines, process for their preparation and their use as pharmaceuticals
IL144370A0 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
HUP0202736A3 (en) Substituted aromatic-ring compounds, process for producing the same, and pharmaceutical compositions containing them and use thereof
HUP0201785A3 (en) Dihydrobenzodiazepins, process for producing them, their use and pharmaceutical compositions containing them
HK1046690A1 (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
HUP0103749A3 (en) Tricyclic delta3-piperidines as pharmaceuticals and process for their preparation
HUP0200376A3 (en) Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use
HK1015763A1 (en) Benzoxazindione derivatives, process for their preparation and their use
HUP0204572A3 (en) Substituierte bisindolylmaleinimide derivatives, process for their preparation and use and pharmaceutcial compositions containing them
ZA9810673B (en) 1-methyl-5-alkysulfonyl-, 1-methyl-5-alkylsulfinyl- and 1-methyl-5-alkylthio-substituted pyrazolylpyrazoles, process for their preparation and their use as herbicides

Legal Events

Date Code Title Description
ERR Corrigendum

Free format text: JOURNAL 8/2005 P. 2781 PATENT APPLICATION NO. 140767 CORRECT INTERNATIONAL PUBLICATION NO. TO WO 2000/004006

FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees